Prostamax
Also known as: Prostamax
Prostamax is a synthetic peptide bioregulator studied in Russian research for supporting prostate tissue function and urinary health in aging males. It belongs to the short-peptide bioregulator family popularized by Khavinson.
Last updated
Mechanism of Action
Prostamax is a short peptide proposed to act as a tissue-specific bioregulator that influences gene expression in prostate epithelial and stromal cells. Preclinical work suggests it modulates proliferation and secretory function, supports normalization of prostate tissue architecture, and may reduce inflammatory and oxidative markers. It is conceptually related to the natural prostate bioregulator Prostatic peptide (Prostatilen/Vitaprost). Evidence is based largely on Russian preclinical and limited clinical observation rather than rigorous controlled trials.
- Half-life
- Short; estimated minutes in circulation for the free peptide
- Administration Routes
- subcutaneous, intramuscular
- Research Status
- Preclinical
Reported Benefits
- Studied for support of prostate tissue function in aging models
- Investigated for improvement of urinary flow parameters
- Proposed anti-inflammatory effects in prostate tissue
- Explored for support of male reproductive health
- Part of a bioregulator class researched for organ-specific aging
Potential Side Effects
- Limited rigorous human safety data
- Possible injection-site irritation
- Theoretical hormonal or urinary symptom changes
- Unknown long-term effects
Common Dosing
For research use only and not medical advice: reported research protocols cite roughly 1-10 mg per administration in courses; no validated standardized human dosing exists.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Active prostate malignancy without clinical supervision
- Known peptide hypersensitivity
- Use without urological evaluation for prostate symptoms
Pancragen
Pancragen is a synthetic short peptide bioregulator (Lys-Glu-Asp-Trp) studied in Russian research for supporting pancreatic function and glucose metabolism. It belongs to the Khavinson family of peptide bioregulators developed to normalize tissue-specific gene expression in aging organs.
Testagen
Testagen is a short synthetic bioregulator peptide from the Khavinson family, studied for effects on the thymus and immune regulation. It is researched for supporting immune balance and healthy aging.
Epitalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the pineal peptide epithalamin, studied for telomerase activation, circadian regulation, and longevity in animal and limited human research.
Vesugen
Vesugen is a short tripeptide bioregulator studied for support of the vascular system and blood-vessel wall integrity. It is part of the Khavinson peptide family aimed at tissue-specific regulation.
- View
Effects of short peptides on lymphocyte chromatin in senile subjects
2004
- View
[The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]
2006
- View
[The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ]
2004
- View
[Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)]
2012